{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:59:30Z","timestamp":1785283170030,"version":"3.55.0"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jdcr.2025.10.057","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T05:08:44Z","timestamp":1762578524000},"page":"229-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Localized granuloma annulare successfully treated with ruxolitinib"],"prefix":"10.1016","volume":"70","author":[{"given":"Julianna","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Leger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jdcr.2025.10.057_bib1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaad.2015.03.054","article-title":"Granuloma annulare: clinical and histologic variants, epidemiology, and genetics","volume":"75","author":"Piette","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2025.10.057_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40257-021-00636-1","article-title":"Granuloma annulare: an updated review of epidemiology, pathogenesis, and treatment options","volume":"23","author":"Joshi","year":"2022","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2025.10.057_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jdcr.2019.10.016","article-title":"Treatment of granuloma annulare with tofacitinib 2% ointment","volume":"6","author":"Damsky","year":"2019","journal-title":"JAAD Case Rep"},{"issue":"1","key":"10.1016\/j.jdcr.2025.10.057_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2024.2313090","article-title":"Oral abrocitinib in the treatment of granuloma annulare: a case report","volume":"35","author":"Liu","year":"2024","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.jdcr.2025.10.057_bib5","first-page":"65","article-title":"Therapeutic success of tofacitinib in granuloma annulare: a retrospective case series of 15 patients","volume":"91","author":"Dev","year":"2025","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5","key":"10.1016\/j.jdcr.2025.10.057_bib6","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jaci.2020.10.012","article-title":"Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib","volume":"147","author":"Wang","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jdcr.2025.10.057_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdcr.2024.05.030","article-title":"Ruxolitinib cream for the treatment of granuloma annulare","volume":"50","author":"Piontkowski","year":"2024","journal-title":"JAAD Case Rep"},{"issue":"1","key":"10.1016\/j.jdcr.2025.10.057_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaad.2019.12.028","article-title":"Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways","volume":"83","author":"Min","year":"2020","journal-title":"J Am Acad Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625005946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625005946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:27:30Z","timestamp":1785281250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512625005946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":8,"alternative-id":["S2352512625005946"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.10.057","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Localized granuloma annulare successfully treated with ruxolitinib","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.10.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}